PIONEERING THERAPEUTIC ADVANCE: SCIENTISTS DISCOVER A MOLECULE IN ARGENTINA THAT PROTECTS THE LIVER AGAINST FULMINANT HEPATITIS
https://resizer.glanacion.com/resizer/v2/57STDCXPMBFQPHDS5JUJETM3RA.jpg?auth=5e6f6d59513705ee1381404c4ccaec1fab651f6f06eb1851f4ceb10650de1283&smart=true&width=1600&height=1200
✍️ Scientists at the University of Austral/Conicet have developed a new therapeutic approach for fulminant hepatitis, a life-threatening liver disease, by blocking a protein called RAC1.
👉 Scientists developed a new therapeutic approach for fulminant hepatitis by blocking the protein RAC1. 👉 The therapy was tested in three animal models and human liver tissue samples, showing promising results. 👉 The study suggests that this therapy could be effective in treating fulminant hepatitis, a disease with limited treatment options.
-- #GuillermoMazzolini #JuanBayo #BárbaraBueloni #EstebanFiore #JulietaComin #UniversityofAustral #Conicet #InstitutoNacionaldeTecnologíaIndustrial(INTI) #health
Loading quoted post…
